Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were rising during early summer 2021 in many countries as a result of the Delta variant. We assessed reverse transcription polymerase chain reaction swab positivity in the Real-time Assessment of Community Transmission-1 (REACT-1) study in England. During June and July 2021, we observed sustained exponential growth with an average doubling time of 25 days, driven by complete replacement of the Alpha variant by Delta and by high prevalence at younger, less-vaccinated ages. Prevalence among unvaccinated people [1.21% (95% credible interval 1.03%, 1.41%)] was three times that among double-vaccinated eople [0.40%(95% credible interval 0.34%, 0.48%]. However, after adjusting for age and other variables, vaccine effectiveness for double-vaccinated people was estimated at between ∼50% and ∼60% during this period in England. Increased socialmixing in the presence of Delta had the potential to generate sustained growth in infections, even at high levels of vaccination.

Original publication

DOI

10.1126/science.abl9551

Type

Journal article

Journal

Science

Publication Date

17/12/2021

Volume

374